Theiler's virus infection provokes the overexpression of genes coding for the chemokine Ip10 (CXCL10) in SJL/J murine astrocytes, which can be inhibited by modulators of estrogen receptors

被引:9
作者
Rubio, Nazario [1 ]
Arevalo, Maria-Angeles [1 ]
Cerciat, Marie [2 ]
Sanz-Rodriguez, Francisco [3 ]
Unkila, Mikko [4 ]
Miguel Garcia-Segura, Luis [1 ]
机构
[1] CSIC, Inst Cajal, E-28002 Madrid, Spain
[2] Univ Strasbourg, Strasbourg, France
[3] Univ Autonoma Madrid, Dept Biol, Madrid, Spain
[4] Hormos Med Ltd, Turku, Finland
关键词
CXCL10; Astrocytes; Encephalomyelitis virus; Demyelination; Estrogens; GAMMA-INDUCIBLE PROTEIN-10; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; IFN-GAMMA; ENCEPHALOMYELITIS VIRUS; DISTINCT ROLES; DTH RESPONSE; IN-VITRO; IP-10; EXPRESSION;
D O I
10.1007/s13365-014-0273-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Theiler's murine encephalomyelitis virus (TMEV) induces demyelination in susceptible strains of mice (SJL/J) through an immunopathological process that is mediated by CD4(+) Th1 T cell. These T cells are chemoattracted to the central nervous system by chemokines. Hence, in this study, we focused on the production of the chemokine "interferon-gamma-inducible protein 10 kDa," or IP-10/CXCL10, by cultured SJL/J mouse astrocytes infected with the BeAn strain of TMEV and its capacity to attract activated T cells. The analysis of the whole murine genome by DNA hybridization with cRNAs from mock- and TMEV-infected cultures revealed the upregulation of six sequences that potentially encode for CXCL10. This increased CXCL10 expression was validated by PCR and qPCR. The presence of this chemokine was further demonstrated by enzyme-linked immunoassay (ELISA). Significantly, astrocytes from BALB/c mice, a strain resistant to demyelination, did not produce CXCL10. The secreted CXCL10 was biologically active, inducing chemoattraction of activated lymphocytes. The inflammatory cytokines, IL-1 alpha, IFN-gamma, and TNF-alpha, were strong inducers of CXCL10 in astrocytes. Serum from TMEV-infected SJL/J but not BALB/c mice contains CXCL10, the levels of which peak at the onset of the clinical disease. Finally, this in vitro inflammation model was fully inhibited by 17 beta-estradiol and four selective estrogen receptor modulators, as demonstrated by ELISA and qPCR.
引用
收藏
页码:485 / 495
页数:11
相关论文
共 42 条
[1]  
Acaz-Fonseca E, 2014, MOL CELL EN IN PRESS
[2]   Inflammation in neurodegenerative diseases [J].
Amor, Sandra ;
Puentes, Fabiola ;
Baker, David ;
van der Valk, Paul .
IMMUNOLOGY, 2010, 129 (02) :154-169
[3]  
[Anonymous], 1999, SYST NOM CHEM
[4]   RANTES: a versatile and controversial chemokine [J].
Appay, V ;
Rowland-Jones, SL .
TRENDS IN IMMUNOLOGY, 2001, 22 (02) :83-87
[5]   Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro [J].
Asensio, VC ;
Maier, J ;
Milner, R ;
Boztug, K ;
Kincaid, C ;
Moulard, M ;
Phillipson, C ;
Lindsley, K ;
Krucker, T ;
Fox, HS ;
Campbell, IL .
JOURNAL OF VIROLOGY, 2001, 75 (15) :7067-7077
[6]   Characterization of chemokines and their receptors in the central nervous system: physiopathological implications [J].
Bajetto, A ;
Bonavia, R ;
Barbero, S ;
Schettini, G .
JOURNAL OF NEUROCHEMISTRY, 2002, 82 (06) :1311-1329
[7]   CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions [J].
Balashov, KE ;
Rottman, JB ;
Weiner, HL ;
Hancock, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6873-6878
[8]   Distinct roles of protein kinase R and toll-like receptor 3 in the activation of astrocytes by viral stimuli [J].
Carpentier, Pamela A. ;
Williams, Bryan R. ;
Miller, Stephen D. .
GLIA, 2007, 55 (03) :239-252
[9]   Selective Estrogen Receptor Modulators Decrease the Production of Interleukin-6 and Interferon-γ-Inducible Protein-10 by Astrocytes Exposed to Inflammatory Challenge In Vitro [J].
Cerciat, M. ;
Unkila, M. ;
Garcia-Segura, L. M. ;
Arevalo, M. -A. .
GLIA, 2010, 58 (01) :93-102
[10]  
CLATCH RJ, 1986, J IMMUNOL, V136, P920